Abstract: Slide Presentations |

Do Diagnoses and Comorbidities Influence Survival and Weaning Success in Patients Requiring Long-term Ventilator Support? FREE TO VIEW

Giorgio R. Sansone, PhD; John J. Vecchione, MD; J. Dermot Frengley, MD, MS*
Author and Funding Information

Coler-Goldwater Specialty Hospital, New York, NY


Chest. 2004;126(4_MeetingAbstracts):756S. doi:10.1378/chest.126.4_MeetingAbstracts.756S
Text Size: A A A
Published online


PURPOSE:  To show the effects on outcomes of primary diagnoses and co-morbidities in 157 patients admitted in 2003 to a long-term ventilator support unit with active weaning. Patients were followed until discharge or 3/31/04.

METHODS:  Data were extracted from medical records. Diagnoses requiring long-term ventilator support recorded; burden of illness from co-morbidities calculated using Cumulative Illness Rating Scale (CIRS) which weights and sums impairments in 14 organ systems (0-4;4=maximum organ impairment: range of sums 0-52). Patients were grouped by diagnoses: Neurological (NEURO) n=62; Cardiopulmonary (CP) n=55; Both (n=40); then divided into potentially weanable or unweanable using established criteria. The weanable were subdivided into weaned (four weeks free from ventilator support) and failed. Between-group comparisons were made.

RESULTS:  No differences existed between diagnostic groups in gender and CIRS scores. Age differences existed between NEURO and CP groups (60±20 yrs vs 72±15; p < 0.01), Both group (67±20 yrs). More NEURO patients were weanable and weaned. Weanable, NEURO60%(37/62), CP34%(19/55), Both37%(15/40) (p = 0.008): weaned, 78%(29/37), 74%(14/19), 67%(10/15), respectively. The end point level of care differed between diagnostic groups: home or nursing facility (lower level); long term acute care (unchanged level); acute care or death (higher level). NEURO; lower23%(14/62), unchanged29%(18/62), higher48%(30/62). CP; lower13%(7/55), unchanged9%(5/55), higher78%(43/55). Both; lower5%(2/4O), unchanged25%(10/40), higher70%(28/40) (p = 0.001). In the weaned groups, these differences were even more evident. CIRS subgroups scores within groups were significantly different. NEURO; weaned 24.86±5.56, failed 29.37±6.57, unweanable 28.78±4.01 (p = 0.013). CP; weaned 22.28±8.50, failed 25.20±8.79, unweanable 29.06±4.50 (p = 0.0034). Both; weaned 26.10±4.53, failed 28.80±3.27, unweanable 29.71±5.86 (p = 0.21).

CONCLUSION:  Neurological patients were the most weanable. Patients in any diagnostic group, who were weanable had better survival outcomes and greater likelihood of going to a less restrictive level of care. These patients had significantly lower burden of illness from co-morbidities.

CLINICAL IMPLICATIONS:  Primary diagnostic groups and co-morbidities have major effects on weaning outcomes and survival. These clinical characteristics should be considered in the selection of patients into an active weaning program.

DISCLOSURE:  J. Frengley, None.

Tuesday, October 26, 2004

12:30 PM- 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543